Home Fairfield Westport’s ViralClear opens phase 2 clinical trial for COVID-19 drug

Westport’s ViralClear opens phase 2 clinical trial for COVID-19 drug

Merimepodib demonstrated decreased viral production of COVID-19 by over 90%, and when combined with Gilead’s remdesivir, to undetectable levels. 

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.